To evaluate the impact of aspirin in prevention of coronary artery disease in superspeciality hospital Jalandhar Punjab, India
Keywords:
Coronary artery disease, aspirin, smoking, hypertensionAbstract
Introduction: Coronary artery disease (CAD), a prevalent cardiovascular ailment, arises from the gradual accumulation of fatty deposits, cholesterol, and other substances within the coronary arteries – the blood vessels responsible for supplying oxygen and nutrients to the heart muscle. Aspirin plays a pivotal role in the management of Coronary Artery Disease (CAD) due to its antiplatelet properties. CAD often involves the formation of blood clots within narrowed coronary arteries, potentially leading to heart attacks. Aspirin, a blood-thinning medication, helps prevent clot formation by inhibiting the aggregation of platelets, which are blood cells involved in clotting. Objective: The objective of this study was to the impact of aspirin in prevention of coronary artery disease in superspeciality hospital Jalandhar Punjab, India. Methodology: The study was conducted in cardiac care unit at Nasa and Hub Superspeciality hospital Jalandhar Punjab and exclusively on patients who presented with any kind of cardiac disorder symptoms. This study was approved by the Ethics committee of Nasa And Hub Superspeciality Hospital. All the subjects have signed the informed consent form. In this study, 200 patients were recruited in NASA AND HUB SUPERSPECIALITY HOSPITAL Jalandhar Punjab from 8th june 2022 to 8th September 2022. Results and Discussion: . In this study population, there were significant differences between male and female concerning cardiovascular risk factors, so cigarette smoking is very prevalent in young group and limited for males. We observed that hypertension and diabetes are present at high level in women than men, and the percentage of hypertension and diabetes increase in both gender with age. In the present study, we examined a representative sample of visits to physicians in the Nasa And Hub Superspeciality Hospital by patients with coronary artery disease, with a focus on visits to cardiologists and primary care physicians by patients in whom aspirin was not contraindicated. Conclusion: Aspirin continues to be the mainstay of antiplatelet therapy in individuals with coronary artery disease (CAD) in this observational study. Patients at a high risk of developing CVD in the future may be advised to take aspirin, but the potential for adverse effects must be recognised in addition to the advantages. As a result of our study, it is imperative to reinforce the need for proper coronary artery disease (CAD) management in order to prevent further coronary artery complications.
Keywords: Coronary artery disease, aspirin, smoking, hypertension
Downloads
References
P.A.J.C.J.o.t.A.S.o.N. McCullough, Coronary artery disease, 2(3) (2007) 611-616.
M. Maqbool, F. Bekele, G.J.B.C.T. Fekadu, Therapy, Treatment strategies against triple-negative breast cancer: an updated review, (2022) 15-24.
P. Libby, P.J.C. Theroux, Pathophysiology of coronary artery disease, 111(25) (2005) 3481-3488.
M. Zehravi, M. Maqbool, I.J.I.j.o.a.m. Ara, health, Polycystic ovary syndrome and infertility: an update, 34(2) (2021) 1-9.
V. Fuster, L. Badimon, J.J. Badimon, J.H.J.N.E.j.o.m. Chesebro, The pathogenesis of coronary artery disease and the acute coronary syndromes, 326(4) (1992) 242-250.
R. Maqbool, M. Maqbool, M. Zehravi, I.J.I.j.o.a.m. Ara, health, Menstrual distress in females of reproductive age: a literature review, 34(2) (2021) 11-17.
N.R. Hertzer, E.G. Beven, J.R. Young, P.J. O'Hara, W. Ruschhaupt 3rd, R.A. Graor, V.G. Dewolfe, L.C.J.A.o.s. Maljovec, Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management, 199(2) (1984) 223.
M. Zehravi, M. Maqbool, I.J.I.J.o.A.M. Ara, Health, Correlation between obesity, gestational diabetes mellitus, and pregnancy outcomes: an overview, 33(6) (2021) 339-345.
C. Shao, J. Wang, J. Tian, Y.-d.J.C.A.D.T. Tang, D. Discovery, Coronary artery disease: from mechanism to clinical practice, (2020) 1-36.
U. Ralapanawa, R.J.J.o.e. Sivakanesan, g. health, Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review, 11(2) (2021) 169.
M. Zehravi, M. Maqbool, I.J.I.J.o.A.M. Ara, Health, Depression and anxiety in women with polycystic ovarian syndrome: a literature survey, 33(6) (2021) 367-373.
R. Bauersachs, U. Zeymer, J.-B. Brière, C. Marre, K. Bowrin, M.J.C.t. Huelsebeck, Burden of coronary artery disease and peripheral artery disease: a literature review, 2019 (2019).
M. Abdar, W. Książek, U.R. Acharya, R.-S. Tan, V. Makarenkov, P.J.C.m. Pławiak, p.i. biomedicine, A new machine learning technique for an accurate diagnosis of coronary artery disease, 179 (2019) 104992.
R.J. Lihite, M. Lahkar, S. Das, D. Hazarika, M. Kotni, M. Maqbool, S.J.A.j.o.m. Phukan, A study on adverse drug reactions in a tertiary care hospital of Northeast India, 53(2) (2017) 151-156.
A. Barham, R. Ibraheem, S.e.H.J.B.C.D. Zyoud, Cardiac self-efficacy and quality of life in patients with coronary heart disease: a cross-sectional study from Palestine, 19(1) (2019) 1-12.
M. Zehravi, M. Maqbool, I.J.O.H. Ara, Healthy lifestyle and dietary approaches to treating polycystic ovary syndrome: a review, 3(1) (2022) 60-65.
M. Zehravi, M. Maqbool, I.J.I.J.o.A.M. Ara, Health, Teenage menstrual dysfunction: an overview, 35(1) (2022) 15-19.
Y. Higashi, S. Gautam, P. Delafontaine, S.J.G.H. Sukhanov, I. Research, IGF-1 and cardiovascular disease, 45 (2019) 6-16.
D. Ornish, S.E. Brown, J. Billings, L. Scherwitz, W.T. Armstrong, T.A. Ports, S.M. McLanahan, R.L. Kirkeeide, K. Gould, R.J.T.L. Brand, Can lifestyle changes reverse coronary heart disease?: The Lifestyle Heart Trial, 336(8708) (1990) 129-133.
J.C. Rutledge, D.A. Hyson, D. Garduno, D.A. Cort, L. Paumer, C.T.J.J.o.C.R. Kappagoda, Prevention, Lifestyle modification program in management of patients with coronary artery disease: the clinical experience in a tertiary care hospital, 19(4) (1999) 226-234.
A. Majeed, R. Bashir, S. Farooq, M.J.J.o.D.D. Maqbool, Therapeutics, Preparation, characterization and applications of nanoemulsions: An insight, 9(2) (2019) 520-527.
S. Khan, M. Cleanthis, J. Smout, M. Flather, G.J.E.J.o.V. Stansby, E. Surgery, Life-style modification in peripheral arterial disease, 29(1) (2005) 2-9.
M. Mohd, M. Maqbool, M.A. Dar, I.J.J.o.D.D. Mushtaq, Therapeutics, Polycystic ovary syndrome, a modern epidemic: an overview, 9(3) (2019) 641-644.
E.B. Winzer, F. Woitek, A.J.J.o.t.A.H.A. Linke, Physical activity in the prevention and treatment of coronary artery disease, 7(4) (2018) e007725.
M. Maqbool, I. Gani, M.A.J.A.J.o.P.R. Dar, Development, Anti-diabetic effects of some medicinal plants in experimental animals: a review, 7(1) (2019) 66-69.
J. Claes, R. Buys, W. Budts, N. Smart, V.A.J.E.j.o.p.c. Cornelissen, Longer-term effects of home-based exercise interventions on exercise capacity and physical activity in coronary artery disease patients: A systematic review and meta-analysis, 24(3) (2017) 244-256.
I. Ara, M. Maqbool, I.J.I.J.o.C.R.i.P. Gani, Pharmacology, Reproductive Health of Women: implications and attributes, (2022) 8-18.
I. Goldenberg, M. Jonas, A. Tenenbaum, V. Boyko, S. Matetzky, A. Shotan, S. Behar, H. Reicher-Reiss, B.I.P.S.G.J.A.o.i. medicine, Current smoking, smoking cessation, and the risk of sudden cardiac death in patients with coronary artery disease, 163(19) (2003) 2301-2305.
R. Bashir, M. Maqbool, I. Ara, M.J.C. Zehravi, An In sight into Novel Drug Delivery System: In Situ Gels, 11(1) (2021) 6.1-6.7.
J. Ludvig, B. Miner, M.J.J.A.H.J. Eisenberg, Smoking cessation in patients with coronary artery disease, 149(4) (2005) 565-572.
M. Maqbool, G. Fekadu, D. Dugassa, F. Bekele, E. Turi, D.J.A.o.N. Simegnew, The pattern of substance abuse in the psychiatry department of a tertiary care of Srinagar hospital, Jammu and Kashmir, India, 7(4) (2020).
P.A. Ades, P.D.J.P.i.c.d. Savage, Potential benefits of weight loss in coronary heart disease, 56(4) (2014) 448-456.
G. Fekadu, F. Bekele, K. Bekele, S. Hanbisa, G. Belay, M.J.C.T. Maqbool, Drug use evaluation of beta-blockers in medical wards of Nedjo general hospital, Western Ethiopia, 2020 (2020).
Q.R. Pack, J.P. Rodriguez-Escudero, R.J. Thomas, P.A. Ades, C.P. West, V.K. Somers, F. Lopez-Jimenez, The prognostic importance of weight loss in coronary artery disease: a systematic review and meta-analysis, Mayo Clinic Proceedings, Elsevier, 2014, pp. 1368-1377.
I. Ara, M. Zehravi, M. Maqbool, I.J.J.o.P.R. Gani, R.S.J.-D.d. org/10.47363/JPRSR/, A review of recent developments and future challenges in the implementation of universal health coverage policy framework in some countries, 127 (2022).
A. Michalsen, P. Grossman, N. Lehmann, N.T. Knoblauch, A. Paul, S. Moebus, T. Budde, G.J.J.P. Dobos, psychosomatics, Psychological and quality-of-life outcomes from a comprehensive stress reduction and lifestyle program in patients with coronary artery disease: results of a randomized trial, 74(6) (2005) 344-352.
M. Maqbool, D. Dugassa, G.J.A.o.N. Fekadu, Adverse drug reactions of antiepileptic drugs in the neurology department of a tertiary care hospital, Srinagar, Jammu & Kashmir, India, 8(2) (2021).
M.J. Mathews, L. Liebenberg, E.H.J.N.j. Mathews, The mechanism by which moderate alcohol consumption influences coronary heart disease, 14 (2015) 1-12.
M. Maqbool, M. Zehravi, R. Maqbool, I.J.C. Ara, An overview about treatment of gestational diabetes mellitus: A short communication, 11(3) (2021) 12.1-12.5.
C. Matsumoto, M.D. Miedema, P. Ofman, J.M. Gaziano, H.D.J.J.o.c.r. Sesso, prevention, An expanding knowledge of the mechanisms and effects of alcohol consumption on cardiovascular disease, 34(3) (2014) 159-171.
M. Zehravi, M. Maqbool, I.J.I.J.o.A.M. Ara, Health, Unfolding the mystery of premenstrual syndrome (PMS): an overview, 35(1) (2022) 9-13.
T.M. Maddox, P.M.J.C.o.i.c. Ho, Medication adherence and the patient with coronary artery disease: challenges for the practitioner, 24(5) (2009) 468-472.
I. Ara, M. Maqbool, B. Bukhari, N. Ara, T.A.J.I.J.o.R.i.P.S. Hajam, Technology, Present status, standardization and safety issues with herbal drugs, 1(3) (2020) 95-101.
S. Baroletti, H.J.C. Dell'Orfano, Medication adherence in cardiovascular disease, 121(12) (2010) 1455-1458.
I. Ara, M. Maqbool, I.J.I.J.o.C.R.i.P. Gani, Pharmacology, Neuroprotective Activity of Herbal Medicinal Products: A Review, (2022) 1-10.
C.B. Mendez, N.C. Salum, C. Junkes, L.N. Amante, C.M.L.J.R.l.-a.d.e. Mendez, Mobile educational follow-up application for patients with peripheral arterial disease, 27 (2019).
M. Maqbool, S. Rasool, M.A. Dar, R. Bashir, M.J.P. Khan, Hepatotoxicity and Hepatoprotective agents: A Mini review, 7(9) (2019) 34-40.
D.T. Zhou, O. Oektedalen, S. Shawarira-Bote, B.J.H.A.-R. Stray-Pedersen, P. Care, Changes in coronary heart disease risk profiles of HIV patients in Zimbabwe over 9 months: a follow-up study, (2016) 165-174.
M. Maqbool, A.M. Dar, S. Rasool, M.J.J.o.A.P.S. Khan, Research, Curious case of drug resistant malaria and artemisinin compounds in the modern era, (2019) 1-4.
M. Maqbool, M.J.I.P.M. Zehravi, Neuromodulation, Neuroprotective role of polyphenols in treatment of neurological disorders: A review, 1(1) (2021).
G.J. Hankey, P.E. Norman, J.W.J.J. Eikelboom, Medical treatment of peripheral arterial disease, 295(5) (2006) 547-553.
R.A. Rayan, I. Zafar, H. Rajab, M.A.M. Zubair, M. Maqbool, S.J.M.L.A.f.S. Hussain, I. Processing, Impact of IoT in Biomedical Applications Using Machine and Deep Learning, (2022) 339-360.
I. Ara, M. Maqbool, G. Fekadu, T.A. Hajam, M.A.J.J.o.A.P.S. Dar, Research, Pharmaceutical significance of Nigella sativa L., a wonder herb, 3(4) (2020) 04-13.
B.D.S.G.J.N.E.J.o. Medicine, A randomized trial of therapies for type 2 diabetes and coronary artery disease, 360(24) (2009) 2503-2515.
R. Maqbool, M. Maqbool, M. Zehravi, I.J.I.J.o.A.M. Ara, Health, Acute neurological conditions during pregnancy and their management: a review, 33(6) (2021) 357-366.
G.C. Fonarow, A. Gawlinski, S. Moughrabi, J.H.J.T.A.j.o.c. Tillisch, Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP), 87(7) (2001) 819-822.
M. Maqbool, M. Zehravi, R. Maqbool, I.J.C. Ara, Study of adverse drug reactions in pulmonary medicine department of a Tertiary care hospital, Srinagar, Jammu & Kashmir, India, 11(2) (2021) 8.1-8.5.
H. Tran, S.S.J.J. Anand, Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease, 292(15) (2004) 1867-1874.
M. Zehravi, R. Maqbool, M. Maqbool, I.J.J.o.P.R.I. Ara, To Identify Patterns of Drug Usage among Patients Who Seek Care in Psychiatry Outpatient Department of a Tertiary Care Hospital in Srinagar, Jammu and Kashmir, India, 33(31A) (2021) 135-140.
N. Clappers, M. Brouwer, F.J.H. Verheugt, Antiplatelet treatment for coronary heart disease, 93(2) (2007) 258-265.
M.J.J.o.A.P.S. Maqbool, Research, Evaluation of drug utilization pattern in the pediatric department of a Tertiary Care Hospital in Srinagar, Jammu & Kashmir, India, (2019) 6-9.
U. Rauch, J. Osende, J. Chesebro, V. Fuster, D. Vorchheimer, K. Harris, P. Harris, D. Sandler, J. Fallon, S.J.A. Jayaraman, Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins, 153(1) (2000) 181-189.
C.G. Mihos, A.M. Pineda, O.J.P.r. Santana, Cardiovascular effects of statins, beyond lipid-lowering properties, 88 (2014) 12-19.
D. Tousoulis, M. Charakida, E. Stefanadi, G. Siasos, G. Latsios, C.J.I.j.o.c. Stefanadis, Statins in heart failure. Beyond the lipid lowering effect, 115(2) (2007) 144-150.
M. Maqbool, I.J.J.o.P.P. Gani, C. Medicine, Utilization of statins in reducing comorbidities of diabetes mellitus: A systematic review, 4(4) (2018).
S. Paravastu, D. Mendonca, A.J.E.j.o.v. Da Silva, e. surgery, Beta blockers for peripheral arterial disease, 38(1) (2009) 66-70.
I. Ara, M. Maqbool, I.J.I.J.o.C.R.i.P. Gani, Pharmacology, Specificity and Personalized medicine: a novel approach to Cancer management, (2022) 11-20.
M. Chonchol, M. Benderly, U.J.N.D.T. Goldbourt, Beta-blockers for coronary heart disease in chronic kidney disease, 23(7) (2008) 2274-2279.
D.P. Leong, J.J. McMurray, P.G. Joseph, S.J.J.o.t.A.C.o.C. Yusuf, From ACE inhibitors/ARBs to ARNIs in coronary artery disease and heart failure (part 2/5), 74(5) (2019) 683-698.
E.L. Gillespie, C.M. White, M. Kardas, M. Lindberg, C.I.J.D.c. Coleman, The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes, 28(9) (2005) 2261-2266.
M.A. Dar, M. Maqbool, I. Gani, I.J.I.J.o.C.R.i.P. Ara, Pharmacology, Menstruation hygiene and related issues in adolescent girls: A brief commentary, (2023) 1-5.
V. Hoang, M. Alam, D. Addison, F. Macedo, S. Virani, Y.J.C.d. Birnbaum, therapy, Efficacy of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in coronary artery disease without heart failure in the modern statin era: a meta-analysis of randomized-controlled trials, 30 (2016) 189-198.
M. Maqbool, M.J.P. Khan, Hypertension and Pregnancy: an important issue, 7(8) (2019) 71-78.
R. GORLIN, N. BRACHFELD, C. MACLEOD, P.J.C. BOPP, Effect of nitroglycerin on the coronary circulation in patients with coronary artery disease or increased left ventricular work, 19(5) (1959) 705-718.
I. Ara, M. Maqbool, M. Zehravi, I.J.A.J.C.B. Gani, Herbs Boosting Immunity in Covid-19: An Overview, 3(3) (2020) 289-94.
Z.H. Sawan, H.M. Soliman, A.E.A. Mostafa, R.A.J.T.E.J.o.H.M. Kamel, A Review on Nitroglycerin: Present and Future, 91(1) (2023) 4972-4974.
M. Zehravi, M. Maqbool, I.J.T.I.J.o.N. Ara, Dietetics, An overview about safety surveillance of adverse drug reactions and pharmacovigilance in India, (2021) 408-418.
E. Sorbets, P.G. Steg, R. Young, N. Danchin, N. Greenlaw, I. Ford, M. Tendera, R. Ferrari, B. Merkely, A.J.E.H.J. Parkhomenko, β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study, 40(18) (2019) 1399-1407.
M. Maqbool, I. Ara, I.J.I.J.o.C.R.i.P. Gani, Pharmacology, The Story of Polycystic Ovarian Syndrome: A Challenging Disorder with Numerous Consequences for Females of Reproductive Age, (2022) 19-31.
R. Bashir, M. Maqbool, M. Zehravi, I.J.A.J.C.S.B. Ara, Utilization of herbal cosmetics: A brief overview, 3 (2021) 277-288.
A.K. Malakar, D. Choudhury, B. Halder, P. Paul, A. Uddin, S.J.J.o.c.p. Chakraborty, A review on coronary artery disease, its risk factors, and therapeutics, 234(10) (2019) 16812-16823.
M. Zehravi, M. Maqbool, I.J.A.J.o.C. Ara, Section B, Curcumin–A promising phytocompound of immense potential, 3 (2021) 271.
S. Jia, Y. Liu, J.J.C.A.D.T. Yuan, D. Discovery, Evidence in guidelines for treatment of coronary artery disease, (2020) 37-73.
M.A. Dar, M. Maqbool, I.J.J.o.E.o.M. Ara, D. Sciences, Metformin and Other Sulfonylureas for Glycemic Control in Type 2 Diabetic Patients at a Tertiary Care Hospital in Jammu & Kashmir, (2023) 197-201.
N. Chen, L. Chen, S. Jiang, Z. Wang, T.J.E. Liu, T. Medicine, Predictive value of P‑selectin and endothelin‑1 for vascular restenosis after interventional procedures for peripheral artery disease, 17(5) (2019) 3907-3912.
M.A. Dar, M. Maqbool, I.J.J.o.E.o.M. Ara, D. Sciences, Patterns of Drug Use in Geriatric Patients at a Tertiary Care Teaching Hospital in Jammu and Kashmir, (2023) 182-186.
R. Loffroy, N. Falvo, C. Galland, L. Fréchier, F. Ledan, M. Midulla, O.J.F.i.C.M. Chevallier, Intravascular ultrasound in the endovascular treatment of patients with peripheral arterial disease: current role and future perspectives, 7 (2020) 551861.
M.A. Dar, M. Maqbool, I.J.J.o.E.o.M. Ara, D. Sciences, Prescription Pattern of Antibiotics in Pulmonary Ward of a Tertiary Care Hospital, Jammu and Kashmir, (2023) 171-175.
S.K. Arramraju, R.K. Janapati, E.S. Kumar, G.R.J.I.H.J. Mandala, National interventional council data for the year 2018-India, 72(5) (2020) 351-355.
M.M. Willie, M.J.A.S.R.P. Maqbool, Access to public health services in South Africa’s rural Eastern Cape Province, 1(2) (2023) 35-54.
F. Darmoch, M.C. Alraies, Y. Al‐Khadra, H. Moussa Pacha, D.S. Pinto, E.A.J.J.o.t.A.H.A. Osborn, Intravascular ultrasound imaging–guided versus coronary angiography–guided percutaneous coronary intervention: a systematic review and meta‐analysis, 9(5) (2020) e013678.
S. Mumtaz, F. Behram, D.K. Jadoon, M. Maqbool, S.A.A. Shah, U.F.J.N. Khawaja, PATTERN OF DRUG USE IN THE DERMATOLOGY DEPARTMENT OF A HOSPITAL FOR COMMON SKIN CONDITIONS, 20(16) (2022) 2804.
M. Maqbool, N. Nasir, S.J.I.A.J.O.P.S. Mustafa, Polycystic in ovarian syndrome and its various treatment strategies, 5(9) (2018) 8470-8478.
S. Völz, B. Redfors, O. Angerås, D. Ioanes, J. Odenstedt, S. Koul, I. Valeljung, C. Dworeck, R. Hofmann, E.J.E.H.J. Hansson, Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR), 42(27) (2021) 2657-2664.
F. Li, G.-W. Shi, X.-L. Yu, R.-X. Song, J.-Q. Xiao, H.-M. Huang, L.-M. Li, L.-Y. Zhang, C. Gong, G.-J.J.B.C.D. Cai, Safety and efficacy of coronary angiography and percutaneous coronary intervention via distal transradial artery access in the anatomical snuffbox: a single-centre prospective cohort study using a propensity score method, 22(1) (2022) 1-8.
M. Maqbool, A. Naeem, S.J.I.A.J.o.P.S. Aamer, Diabetes mellitus and its various management strategies in practice, 5(8) (2018) 8163-+.
J. Aoki, K.J.C.I. Tanabe, Therapeutics, Mechanisms of drug-eluting stent restenosis, 36 (2021) 23-29.
M. Maqbool, S. Tariq, S.J.I.A.J.o.P.S. Amjad, Prescribing practices in pediatrics and drug utilization studies promoting pediatric health, 5(8) (2018) 8070-8076.
S. Kuramitsu, S. Sonoda, K. Ando, H. Otake, M. Natsuaki, R. Anai, Y. Honda, K. Kadota, Y. Kobayashi, T.J.C.i. Kimura, therapeutics, Drug-eluting stent thrombosis: current and future perspectives, 36 (2021) 158-168.
M.V. Madhavan, J.P. Howard, A. Naqvi, O. Ben-Yehuda, B. Redfors, M. Prasad, B. Shahim, M.B. Leon, S. Bangalore, G.W.J.E.H.J. Stone, Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials, 42(27) (2021) 2643-2654.
M. Maqbool, S. Javed, A.A.J.I.A.J.O.P.S. Bajwa, Assessment OF pain management IN postoperative cases using different scales and questionnaires, 6(1) (2019) 983-987.
H. Jinnouchi, S. Torii, A. Sakamoto, F.D. Kolodgie, R. Virmani, A.V.J.N.R.C. Finn, Fully bioresorbable vascular scaffolds: lessons learned and future directions, 16(5) (2019) 286-304.
S.-W. Baek, D.-S. Kim, D.H. Song, H.B. Kim, S. Lee, J.H. Kim, J.-K. Lee, Y.J. Hong, C.G. Park, D.K.J.B.R. Han, Reduced restenosis and enhanced re-endothelialization of functional biodegradable vascular scaffolds by everolimus and magnesium hydroxide, 26(1) (2022) 1-17.
M. Maqbool, W. Shabbir, S.J.I.A.J.O.P.S. Aamir, Adverse events of blood transfusion and blood safety in clinical practice, 5(8) (2018) 8254-8259.
A. Chaus, B.F.J.C.D. Uretsky, Therapy, Bioresorbable Vascular Scaffolds: a Dissolving Dream?, 37(1) (2023) 1-3.
M. Maqbool, U. Ikram, A.J.I.A.J.O.P.S. Anwar, Adverse drug reaction monitoring and occurrence in drugs used in pulmonary disorders, 5(8) (2018) 8060-8065.
S.K. Sharma, M.I. Tomey, P.S. Teirstein, A.S. Kini, A.B. Reitman, A.C. Lee, P. Généreux, J.W. Chambers, C.L. Grines, S.I.J.C.C.I. Himmelstein, North American expert review of rotational atherectomy, 12(5) (2019) e007448.
F. Bouisset, E. Barbato, K. Reczuch, S. Dobrzycki, M. Meyer-Gessner, E. Bressollette, G. Cayla, T. Lhermusier, W. Zajdel, M.J.E.J.o.E.i.C.w.t.W.G.o.I.C.o.t.E.S.o.C. Ferenc, Clinical outcomes of PCI with rotational atherectomy: the European multicentre Euro4C registry, 16(4) (2020) e305-e312.
K. Jin, S. Khonsari, R. Gallagher, P. Gallagher, A.M. Clark, B. Freedman, T. Briffa, A. Bauman, J. Redfern, L.J.E.J.o.C.N. Neubeck, Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review and meta-analysis, 18(4) (2019) 260-271.
K. Rees, A. Takeda, N. Martin, L. Ellis, D. Wijesekara, A. Vepa, A. Das, L. Hartley, S.J.C.D.o.S.R. Stranges, Mediterranean‐style diet for the primary and secondary prevention of cardiovascular disease, (3) (2019).
S.K. Zyryanov, S.B. Fitilev, A.V. Vozzhaev, I.I. Shkrebniova, N.N. Shindryaeva, D.A. Klyuev, L.N. Stepanyan, N.N. Landyshev, Y.G.J.R.R.i.P. Voronko, Medication adherence in patients with stable coronary artery disease in primary care, 6(2) (2020) 97-103.
T.A. Wadden, J.S. Tronieri, M.L.J.A.p. Butryn, Lifestyle modification approaches for the treatment of obesity in adults, 75(2) (2020) 235.
G.K. Bhatti, A.P. Reddy, P.H. Reddy, J.S.J.F.i.a.n. Bhatti, Lifestyle modifications and nutritional interventions in aging-associated cognitive decline and Alzheimer’s disease, 11 (2020) 369.
P. Jepma, H.T. Jorstad, M. Snaterse, G. Ter Riet, H. Kragten, S. Lachman, M. Minneboo, S.M. Boekholdt, R.J. Peters, W.S.J.H. Op Reimer, Lifestyle modification in older versus younger patients with coronary artery disease, 106(14) (2020) 1066-1072.
M.-E. Piché, P. Poirier, A. Marette, P. Mathieu, V. Levesque, K. Bibeau, E. Larose, J.-P.J.M.S. Despres, R. Disorders, Benefits of 1-year lifestyle modification program on exercise capacity and diastolic function among coronary artery disease men with and without type 2 diabetes, 17(3) (2019) 149-159.
C. Ge, J. Ma, Y. Xu, Y.-J. Shi, C.-H. Zhao, L. Gao, J. Bai, Y. Wang, Z.-J. Sun, J.J.J.o.g.c.J. Guo, Predictors of adherence to home-based cardiac rehabilitation program among coronary artery disease outpatients in China, 16(10) (2019) 749.
P.C. Hong, K.J. Chen, Y.C. Chang, S.M. Cheng, H.H.J.J.o.N.S. Chiang, Effectiveness of theory‐based health information technology interventions on coronary artery disease self‐management behavior: a clinical randomized waitlist‐controlled trial, 53(4) (2021) 418-427.
S.V. Arnold, D.L. Bhatt, G.W. Barsness, A.L. Beatty, P.C. Deedwania, S.E. Inzucchi, M. Kosiborod, L.A. Leiter, K.J. Lipska, J.D.J.C. Newman, Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association, 141(19) (2020) e779-e806.
B.J. Turner, C.S. Hollenbeak, M. Weiner, T. Ten Have, S.S.J.A.o.i.m. Tang, Effect of unrelated comorbid conditions on hypertension management, 148(8) (2008) 578-586.
P.K. Newland, R. Lorenz, C. Budhathoki, M.P.J.C.n.r. Jensen, The presence of symptoms with comorbid conditions in individuals with multiple sclerosis (MS), 25(5) (2016) 532-548.
R. Ferrari, H. Abergel, I. Ford, K.M. Fox, N. Greenlaw, P.G. Steg, D. Hu, M. Tendera, J.-C. Tardif, C.i.J.I.j.o. cardiology, Gender-and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease, 167(6) (2013) 2938-2943.
Published
Issue
Section
License
Copyright (c) 2023 Abrar Bashir Malik, Mashooq Ahmad Mir, Zulfkar Qadrie, MOHD ALTAF DAR
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
The submitted papers are assumed to contain no proprietary material unprotected by patent or patent application; responsibility for technical content and for protection of proprietary material rests solely with the author(s) and their organizations and is not the responsibility of the journal. The main (first/corresponding) author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the responsibility of the author to obtain all necessary copyright release permissions for the use of any copyrighted materials in the manuscript prior to the submission.
What are my rights as an author?
It is important to check the policy for the journal to which you are submitting or publishing to establish your rights as
Author. Journal's standard policies allow the following re-use rights:
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to obtain publishing rights without restrictions.
- You may do whatever you wish with the version of the article you submitted to the journal.
- Once the article has been accepted for publication, you may post the accepted version of the article on your own personal website, your department's website or the repository of your institution without any restrictions.
- You may not post the accepted version of the article in any repository other than those listed above (i.e. you may not deposit in the repository of another institution or a subject-matter repository) until 12 months after publication of the article in the journal.
- You may use the published article for your own teaching needs or to supply on an individual basis to research colleagues, provided that such supply is not for commercial purposes.
